Ernexa Therapeutics Inc.
USD8.00
-1.12 (-12.28%)
CEO
Sanjeev Luther
IPO Date
1991-08-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$9.08
Prev. Close
$9.12
Day Low
$8.00
Day High
$9.08
52W Low
$3.18
52W High
$75.00
Market Cap
$0.00B
Volume
0.05M
| 4,000,000 |
| $0.68 |
| 7 Jul 2025 | Gurrola Sandra M | Sr. VP of Finance | M-Exempt | Acquired | 30 | $0.00 |
| 7 Jul 2025 | Gurrola Sandra M | Sr. VP of Finance | M-Exempt | Acquired | 30 | $0.00 |
| 11 Jun 2025 | Cherington Charles | 10 percent owner | P-Purchase | Acquired | 21,241,163 | $0.10 |
| 26 Feb 2025 | Kim Tony | — | Disposed | 0 | $0.00 |
| 26 Feb 2025 | Menge Steven Reid | — | Disposed | 0 | $0.00 |
| 10 Feb 2025 | Gurrola Sandra M | Sr. VP of Finance | A-Award | Acquired | 150,000 | $0.34 |
| 10 Feb 2025 | Bristol James Arthur | director | A-Award | Acquired | 72,074 | $0.34 |
| 25 Jun 2024 | Gurrola Sandra M | Sr. VP of Finance | M-Exempt | Acquired | 437 | $0.00 |